New scan aims to pinpoint aggressive breast cancer
NCT ID NCT05634954
Summary
This early-stage study aimed to test a new radioactive tracer for PET scans, called [18F]GEH121224, to see if it could better detect HER2-positive breast cancer tumors. The study planned to enroll 12 women with advanced breast cancer to check the safety of the tracer and find the best time to take scan images after injection. The goal was to develop a more precise tool to see where and how much HER2-positive cancer is present in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Texas MD Anderson Cancer Centre
Houston, Texas, 77030-4008, United States
Conditions
Explore the condition pages connected to this study.